Faculdade de Medicina, Departamento de Molestias Infecciosas e Parasitarias, Universidade de São Paulo, Sao Paulo, Brazil.
Instituto de Ensino e Pesquisa, Hospital Sírio-Libanês, Sao Paulo, Brazil.
AIDS Res Hum Retroviruses. 2023 Jan;39(1):44-49. doi: 10.1089/AID.2021.0197. Epub 2022 Nov 29.
Identification of mechanisms of hepatitis C virus (HCV) acquisition among HIV-infected people is critical for prevention guidance. The aim of this study was to investigate risk factors for HCV infection and variations in HCV genotype distribution in a cohort of HIV-HCV coinfected patients in Brazil. This was a cross-sectional observational epidemiological study of a cohort of HIV-HCV coinfected individuals seen at a referral center for HIV-infected patients in the city of São Paulo between January and December 2017. The time of HCV acquisition, as determined by chart review, was categorized as before 2000, between 2000 and 2009, and from 2010 onward. HCV genotypes were determined by gene amplification and analysis. Among 3,143 HIV-infected individuals analyzed, 362 (11.5%) were HCV-HIV coinfected. Overall, the reported modes of HCV acquisition were sexual exposure in 172 (47.5%), injection drug use (IDU) in 86 (23.8%), use of inhaled drugs in 67 (18.5%) and blood transfusion in 10 (2.8%) individuals. All individuals who acquired HCV after IDU became infected before 2010. HCV acquisition by sexual contact was reported by 26.4%, 65.9%, and 63.8% of patients before 2000, between 2000 and 2009, and from 2010, respectively. There was an increase ( < .001) in the proportion of cases due to sexual transmission from the period before 2000 (26.4%) to between 2000 and 2009 (65.9%). There was no corresponding increase from 2000 and 2009 to after 2010 ( = .751). HCV genotype 1 was most prevalent at all time periods. The genotype 3 frequency decreased over time (test for trend < .001), whereas genotype 4, extremely uncommon before 2010, became the second most prevalent genotype from 2010 onward. In HIV-infected individuals in Sao Paulo, Brazil, sexual transmission has replaced IDU as the most frequent mode of HCV acquisition.
鉴定 HIV 感染者中丙型肝炎病毒 (HCV) 的获得机制对于预防指导至关重要。本研究的目的是调查巴西 HIV-HCV 合并感染患者队列中 HCV 感染的危险因素和 HCV 基因型分布的变化。这是一项在 2017 年 1 月至 12 月期间圣保罗市 HIV 感染患者转诊中心就诊的 HIV-HCV 合并感染患者队列的横断面观察性流行病学研究。通过图表审查确定 HCV 获得的时间,分为 2000 年前、2000 年至 2009 年和 2010 年后。通过基因扩增和分析确定 HCV 基因型。在分析的 3143 名 HIV 感染者中,362 名(11.5%)为 HCV-HIV 合并感染。总体而言,报告的 HCV 获得模式为性接触 172 例(47.5%)、静脉注射药物使用 86 例(23.8%)、吸入药物使用 67 例(18.5%)和输血 10 例(2.8%)。所有因静脉注射药物使用而感染 HCV 的人都在 2010 年前感染。性接触感染 HCV 的患者分别有 26.4%、65.9%和 63.8%在 2000 年前、2000 年至 2009 年和 2010 年后报告,差异有统计学意义( < .001)。性传播的比例从 2000 年前(26.4%)到 2000 年至 2009 年(65.9%)有所增加( < .001)。但从 2000 年至 2009 年到 2010 年后,这种增加并没有相应增加( = .751)。所有时间段 HCV 基因型 1 最常见。基因型 3 的频率随时间降低(趋势检验 < .001),而基因型 4 在 2010 年前极少见,自 2010 年以来成为第二常见的基因型。在巴西圣保罗的 HIV 感染者中,性传播已取代静脉注射药物使用成为 HCV 获得的最常见模式。